Cancer Res 2008, 68:379–387 PubMedCrossRef 45 IARC Working Group

Cancer Res 2008, 68:379–387.PubMedCrossRef 45. IARC Working Group on the Evaluation of Carfinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994, 61:1–241. 46. Genta RM: Gastric cancer: a well-behaved Helicobacter pylori-related disease? Dig Dis Sci 2011, 56:923–925.PubMedCrossRef 47. Mishra RR, Tewari M, Shukla HS: Helicobacter species

and pathogenesis of gallbladder cancer. Hepatobiliary Pancreat Dis Int 2010, 9:129–134.PubMed 48. Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A: Extragastric manifestations selleck chemical of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008,13(Suppl 1):47–57.PubMedCrossRef 49. Naito Y, Ito M, Watanabe T, Suzuki H: Biomarkers in patients

with gastric inflammation: a systematic review. Digestion 2005, 72:164–180.PubMedCrossRef 50. Sharma SA, Tummuru MK, Miller GG, Blaser MJ: Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995, 63:1681–1687.PubMed 51. Kim SY, Lee YC, Kim HK, Blaser MJ: Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell Microbiol 2006, 8:97–106.PubMedCrossRef 52. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.: Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med 2005, 30:83–88.PubMed 53. Kido S, Kitadai Y, Hattori N, Haruma K, Kido T, Ohta M, et al.: Interleukin 8 and vascular endothelial growth DAPT nmr factor–prognostic factors in human gastric carcinomas? Eur J Cancer 2001, 37:1482–1487.PubMedCrossRef 54. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki

H, et al.: Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998, 152:93–100.PubMed 55. Bartels M, Schweda AT, Dreikhausen U, Frank R, Resch K, Beil W, et al.: Peptide-mediated disruption of NFkappaB/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori. J Immunol 2007, 179:7605–7613.PubMed 56. Keates S, Hitti YS, Upton M, Kelly CP: Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology many 1997, 113:1099–1109.PubMedCrossRef 57. Shih YT, Wu DC, Liu CM, Yang YC, Chen IJ, Lo YC: San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells. J Ethnopharmacol 2007, 112:537–544.PubMedCrossRef 58. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD: Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998, 160:2401–2407.PubMed 59. Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, et al.

Comments are closed.